These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 38552119)

  • 1. Parkinson's Disease is Predominantly a Genetic Disease.
    Lim SY; Klein C
    J Parkinsons Dis; 2024; 14(3):467-482. PubMed ID: 38552119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
    Cook L; Verbrugge J; Schwantes-An TH; Schulze J; Foroud T; Hall A; Marder KS; Mata IF; Mencacci NE; Nance MA; Schwarzschild MA; Simuni T; Bressman S; Wills AM; Fernandez HH; Litvan I; Lyons KE; Shill HA; Singer C; Tropea TF; Vanegas Arroyave N; Carbonell J; Cruz Vicioso R; Katus L; Quinn JF; Hodges PD; Meng Y; Strom SP; Blauwendraat C; Lohmann K; Casaceli C; Rao SC; Ghosh Galvelis K; Naito A; Beck JC; Alcalay RN
    Brain; 2024 Aug; 147(8):2668-2679. PubMed ID: 39074992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
    Westenberger A; Skrahina V; Usnich T; Beetz C; Vollstedt EJ; Laabs BH; Paul JJ; Curado F; Skobalj S; Gaber H; Olmedillas M; Bogdanovic X; Ameziane N; Schell N; Aasly JO; Afshari M; Agarwal P; Aldred J; Alonso-Frech F; Anderson R; Araújo R; Arkadir D; Avenali M; Balal M; Benizri S; Bette S; Bhatia P; Bonello M; Braga-Neto P; Brauneis S; Cardoso FEC; Cavallieri F; Classen J; Cohen L; Coletta D; Crosiers D; Cullufi P; Dashtipour K; Demirkiran M; de Carvalho Aguiar P; De Rosa A; Djaldetti R; Dogu O; Dos Santos Ghilardi MG; Eggers C; Elibol B; Ellenbogen A; Ertan S; Fabiani G; Falkenburger BH; Farrow S; Fay-Karmon T; Ferencz GJ; Fonoff ET; Fragoso YD; Genç G; Gorospe A; Grandas F; Gruber D; Gudesblatt M; Gurevich T; Hagenah J; Hanagasi HA; Hassin-Baer S; Hauser RA; Hernández-Vara J; Herting B; Hinson VK; Hogg E; Hu MT; Hummelgen E; Hussey K; Infante J; Isaacson SH; Jauma S; Koleva-Alazeh N; Kuhlenbäumer G; Kühn A; Litvan I; López-Manzanares L; Luxmore M; Manandhar S; Marcaud V; Markopoulou K; Marras C; McKenzie M; Matarazzo M; Merello M; Mollenhauer B; Morgan JC; Mullin S; Musacchio T; Myers B; Negrotti A; Nieves A; Nitsan Z; Oskooilar N; Öztop-Çakmak Ö; Pal G; Pavese N; Percesepe A; Piccoli T; Pinto de Souza C; Prell T; Pulera M; Raw J; Reetz K; Reiner J; Rosenberg D; Ruiz-Lopez M; Ruiz Martinez J; Sammler E; Santos-Lobato BL; Saunders-Pullman R; Schlesinger I; Schofield CM; Schumacher-Schuh AF; Scott B; Sesar Á; Shafer SJ; Sheridan R; Silverdale M; Sophia R; Spitz M; Stathis P; Stocchi F; Tagliati M; Tai YF; Terwecoren A; Thonke S; Tönges L; Toschi G; Tumas V; Urban PP; Vacca L; Vandenberghe W; Valente EM; Valzania F; Vela-Desojo L; Weill C; Weise D; Wojcieszek J; Wolz M; Yahalom G; Yalcin-Cakmakli G; Zittel S; Zlotnik Y; Kandaswamy KK; Balck A; Hanssen H; Borsche M; Lange LM; Csoti I; Lohmann K; Kasten M; Brüggemann N; Rolfs A; Klein C; Bauer P
    Brain; 2024 Aug; 147(8):2652-2667. PubMed ID: 39087914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease.
    Chen Y; Gu X; Ou R; Zhang L; Hou Y; Liu K; Cao B; Wei Q; Li C; Song W; Zhao B; Wu Y; Cheng J; Shang H
    Mov Disord; 2020 Nov; 35(11):2046-2055. PubMed ID: 32677286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
    Monfrini E; Di Fonzo A
    Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase 1 and leucine-rich repeat kinase 2 in Parkinson disease and interplay between the two genes.
    Lee CY; Menozzi E; Chau KY; Schapira AHV
    J Neurochem; 2021 Dec; 159(5):826-839. PubMed ID: 34618942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.
    Volta M
    Neurotherapeutics; 2023 Jan; 20(1):127-139. PubMed ID: 36085537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.
    von Linstow CU; Gan-Or Z; Brundin P
    Transl Neurodegener; 2020 Oct; 9(1):39. PubMed ID: 33066808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.
    Blauwendraat C; Heilbron K; Vallerga CL; Bandres-Ciga S; von Coelln R; Pihlstrøm L; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Siitonen A; Iwaki H; Leonard H; Noyce AJ; Tan M; Gibbs JR; Hernandez DG; Scholz SW; Jankovic J; Shulman LM; Lesage S; Corvol JC; Brice A; van Hilten JJ; Marinus J; ; Eerola-Rautio J; Tienari P; Majamaa K; Toft M; Grosset DG; Gasser T; Heutink P; Shulman JM; Wood N; Hardy J; Morris HR; Hinds DA; Gratten J; Visscher PM; Gan-Or Z; Nalls MA; Singleton AB;
    Mov Disord; 2019 Jun; 34(6):866-875. PubMed ID: 30957308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors.
    Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1992-2000. PubMed ID: 30481588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis.
    Huang J; Cheng Y; Li C; Shang H
    Transl Neurodegener; 2022 Apr; 11(1):21. PubMed ID: 35395825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of p.G2019S Mutation in the
    Usenko TS; Timofeeva A; Beletskaia M; Basharova K; Baydakova G; Bezrukova A; Grunina M; Emelyanov A; Miliukhina I; Zakharova E; Pchelina S
    J Integr Neurosci; 2024 Jan; 23(1):16. PubMed ID: 38287861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: from monogenic forms to genetic susceptibility factors.
    Lesage S; Brice A
    Hum Mol Genet; 2009 Apr; 18(R1):R48-59. PubMed ID: 19297401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of Parkinson disease.
    Bekris LM; Mata IF; Zabetian CP
    J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):228-42. PubMed ID: 20938043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for Parkinson's disease in clinical practice.
    Gasser T
    J Neural Transm (Vienna); 2023 Jun; 130(6):777-782. PubMed ID: 36929227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.